WebJun 29, 2024 · Doctors typically diagnose them in the late stages of cancers such as ovarian cancer due to vague symptoms. These include: abdominal bloating abdominal swelling nausea indigestion anorexia... WebJul 8, 2024 · Incidence and Mortality. Germ cell tumors of the ovary are uncommon but aggressive tumors, seen most often in young women and adolescent girls. These tumors are frequently unilateral and are generally curable if found and treated early. The use of combination chemotherapy after initial surgery has dramatically improved the prognosis …
Phase 3 Trial Further Examines Maintenance Mirvetuximab …
WebLong-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer ... WebJun 8, 2024 · Patients with recurrent platinum-resistant ovarian cancer who had received up to 4 prior chemotherapeutic regimens were randomly assigned 1:1:1 to receive 150 mg of intermittent relacorilant plus 80 mg/m 2 of nab-paclitaxel (60 patients), 100 mg of continuous relacorilant plus 80 mg/m 2 of nab-paclitaxel (58 patients), or 100 mg/m 2 of … building a dice table
Improved prognosis for recurrent epithelial ovarian …
WebFeb 14, 2024 · Among the multiple prognostic factors reported, menopause, tumor diameter, estrogen and CA125 levels, International Federation of Gynecology and Obstetrics (FIGO) staging, residual lesions, multisite recurrence, and presence of mitotic figures have been mentioned as factors associated with the prognosis [ 7, 8, 9, 10 ]. WebRecurrent ovarian cancer patients treated between 2007 and 2024 were divided into two groups according to their bevacizumab status. The primary endpoints were overall survival (OS) and safety. Three hundred and ninety-six patients enrolled in this study, 200 (50.5%) received bevacizumab while 196 (49.5%) patients never received bevacizumab. WebJan 23, 2024 · Although up to 25% of women with ovarian cancer have innately (or primary) platinum-refractory disease, most patients are sensitive to front-line platinum therapy but will unfortunately develop recurrence and acquire progressive resistance over time. building a digital clock from scratch